EP Patent

EP2085398A1 — Pyrazolopyrimidines, a process for their preparation and their use as medicine

Assigned to Merz Pharma GmbH and Co KGaA · Expires 2009-08-05 · 17y expired

What this patent protects

The invention relates to pyrazolopyrimidine derivatives of Formula I wherein R 1 represents chloro or bromo; A represents as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The…

USPTO Abstract

The invention relates to pyrazolopyrimidine derivatives of Formula I wherein R 1 represents chloro or bromo; A represents as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP2085398A1
Jurisdiction
EP
Classification
—
Expires
2009-08-05
Drug substance claim
No
Drug product claim
No
Assignee
Merz Pharma GmbH and Co KGaA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.